
Pieces: A leading healthcare company specializing in AI and technology solutions.
Founded with a mission to revolutionize healthcare through artificial intelligence, Pieces is a leading technology company that specializes in AI-driven solutions for the medical field. The company's core vision is to alleviate clinician burnout and enhance patient care by automating and optimizing clinical documentation processes. Pieces offers products that summarize, chart, and draft clinical notes within electronic health records (EHR), thereby streamlining workflows for doctors and nurses. Their market focus is primarily on healthcare providers looking to improve efficiency and patient outcomes through advanced AI technologies.
Notable figures associated with Pieces include a team of seasoned healthcare professionals and AI experts who drive the company's innovative solutions. The company has garnered attention from prominent investors in the tech and healthcare sectors, contributing to its rapid growth and development. Key achievements include the successful implementation of their AI solutions in various healthcare settings, leading to measurable improvements in documentation accuracy and reductions in clinician workload. Overall, Pieces has made a significant impact on the healthcare industry by leveraging AI to support medical professionals and enhance patient care.

Notable Health
notablehealth.com

AZmed
azmed.co

Augmedix
augmedix.com

Regard
withregard.com

Sopris Health
soprishealth.com

Knowtex
knowtex.ai

Suki
suki.ai

RAD AI
radai.com

Phraze
phraze.co

Curai
curai.com

Sanus Solutions
sanussolutions.com

Glass Health
glass.health

care.ai
care.ai

Health at Scale
healthatscale.com

Mdops
mdops.com
Companies similar to Pieces include Notable Health, AZmed, Augmedix and Regard.
Pieces was founded in 2015.
Pieces' headquarters is located in Irving, TX, US.
Pieces' most recent funding round was for $25.7M (USD) in January 2020.
As of Jan 7, 2020, Pieces has raised a total of $61.5M (USD).
Pieces has 59 employees as of Feb 5, 2024.